These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8215304)

  • 1. Effects of tumor necrosis factor-alpha treatment on mortality in murine cytomegalovirus-infected mice.
    Anderson KP; Lie YS; Low MA; Fennie EH
    Antiviral Res; 1993 Aug; 21(4):343-55. PubMed ID: 8215304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
    Orange JS; Wang B; Terhorst C; Biron CA
    J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced mortality in murine cytomegalovirus infected mice following prophylactic murine interferon-gamma treatment.
    Fennie EH; Lie YS; Low MA; Gribling P; Anderson KP
    Antiviral Res; 1988 Nov; 10(1-3):27-39. PubMed ID: 2852918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor.
    Lucin P; Jonjić S; Messerle M; Polić B; Hengel H; Koszinowski UH
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():101-10. PubMed ID: 8113718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor.
    Lenzo JC; Fairweather D; Shellam GR; Lawson CM
    Cell Immunol; 2001 Oct; 213(1):52-61. PubMed ID: 11747356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical response to prophylactic Didox (N-3, 4 trihydroxybenzamide) treatment in murine cytomegalovirus-infected mice.
    Go V; Tang-Feldman YJ; Lochhead SR; Lochhead GR; Yu CQ; Elford HL; Inayat MS; Oakley OR; Pomeroy C
    Antivir Ther; 2011; 16(8):1277-86. PubMed ID: 22155909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon.
    Heise MT; Pollock JL; O'Guin A; Barkon ML; Bormley S; Virgin HW
    Virology; 1998 Feb; 241(2):331-44. PubMed ID: 9499808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to murine cytomegalovirus retinitis during progression of MAIDS: correlation with intraocular levels of tumor necrosis factor-alpha and interferon-gamma.
    Dix RD; Cousins SW
    Curr Eye Res; 2004; 29(2-3):173-80. PubMed ID: 15512964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha-induced apoptosis in murine cytomegalovirus retinitis.
    Zhou J; Zhang M; Atherton SS
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1691-700. PubMed ID: 17389501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic anti-HSV effect of tumor necrosis factor alpha and interferon gamma in human corneal fibroblasts is associated with interferon beta induction.
    Chen SH; Oakes JE; Lausch RN
    Antiviral Res; 1993 Sep; 22(1):15-29. PubMed ID: 8250541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection.
    Pavić I; Polić B; Crnković I; Lucin P; Jonjić S; Koszinowski UH
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2215-23. PubMed ID: 8105025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development.
    Kosmac K; Bantug GR; Pugel EP; Cekinovic D; Jonjic S; Britt WJ
    PLoS Pathog; 2013 Mar; 9(3):e1003200. PubMed ID: 23505367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vgamma1+ gammadelta T cells play protective roles at an early phase of murine cytomegalovirus infection through production of interferon-gamma.
    Ninomiya T; Takimoto H; Matsuzaki G; Hamano S; Yoshida H; Yoshikai Y; Kimura G; Nomoto K
    Immunology; 2000 Feb; 99(2):187-94. PubMed ID: 10692035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation.
    Roback JD; Hossain MS; Lezhava L; Gorechlad JW; Alexander SA; Jaye DL; Mittelstaedt S; Talib S; Hearst JE; Hillyer CD; Waller EK
    J Immunol; 2003 Dec; 171(11):6023-31. PubMed ID: 14634114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection.
    Orange JS; Biron CA
    J Immunol; 1996 Jun; 156(12):4746-56. PubMed ID: 8648121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active and inactive influenza virus induction of tumor necrosis factor-alpha and nitric oxide in J774.1 murine macrophages: modulation by interferon-gamma and failure to induce apoptosis.
    McKinney LC; Galliger SJ; Lowy RJ
    Virus Res; 2003 Nov; 97(2):117-26. PubMed ID: 14602203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of BMS-180194 against experimental cytomegalovirus infections in immunocompromised mice.
    Yang H; Drain RL; Franco CA; Clark JM
    Antiviral Res; 1996 Mar; 29(2-3):233-41. PubMed ID: 8739602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.
    Steinberg C; Eisenächer K; Gross O; Reindl W; Schmitz F; Ruland J; Krug A
    Eur J Immunol; 2009 Apr; 39(4):1007-18. PubMed ID: 19283778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of hochu-ekki-to, a Chinese traditional herbal medicine against murine cytomegalovirus infection.
    Hossain MS; Takimoto H; Hamano S; Yoshida H; Ninomiya T; Minamishima Y; Kimura G; Nomoto K
    Immunopharmacology; 1999 Apr; 41(3):169-81. PubMed ID: 10428645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nitric oxide synthase type 2 in acute infection with murine cytomegalovirus.
    Noda S; Tanaka K; Sawamura S; Sasaki M; Matsumoto T; Mikami K; Aiba Y; Hasegawa H; Kawabe N; Koga Y
    J Immunol; 2001 Mar; 166(5):3533-41. PubMed ID: 11207313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.